Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology.
Saved in:
| Title: | Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. |
|---|---|
| Authors: | Chou DB; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Frismantas V; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Milton Y; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., David R; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Pop-Damkov P; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA., Ferguson D; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA., MacDonald A; Clinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK., Vargel Bölükbaşı Ö; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Joyce CE; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Moreira Teixeira LS; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Rech A; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Chemical Engineering, Loughborough University, Loughborough, UK., Jiang A; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA., Calamari E; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Jalili-Firoozinezhad S; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal., Furlong BA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., O'Sullivan LR; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Ng CF; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Choe Y; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Marquez S; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Myers KC; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH, USA., Weinberg OK; Department of Pathology, Boston Children's Hospital, Boston, MA, USA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Novak R; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Levy O; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Prantil-Baun R; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Novina CD; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Shimamura A; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Ewart L; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ingber DE; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA. don.ingber@wyss.harvard.edu. |
| Source: | Nature biomedical engineering [Nat Biomed Eng] 2020 Apr; Vol. 4 (4), pp. 477. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32051581 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chou+DB%22">Chou DB</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Frismantas+V%22">Frismantas V</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Milton+Y%22">Milton Y</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22David+R%22">David R</searchLink>; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Pop-Damkov+P%22">Pop-Damkov P</searchLink>; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ferguson+D%22">Ferguson D</searchLink>; DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22MacDonald+A%22">MacDonald A</searchLink>; Clinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Vargel+Bölükbaşı+Ö%22">Vargel Bölükbaşı Ö</searchLink>; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Joyce+CE%22">Joyce CE</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moreira+Teixeira+LS%22">Moreira Teixeira LS</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rech+A%22">Rech A</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Chemical Engineering, Loughborough University, Loughborough, UK.<br /><searchLink fieldCode="AU" term="%22Jiang+A%22">Jiang A</searchLink>; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Calamari+E%22">Calamari E</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jalili-Firoozinezhad+S%22">Jalili-Firoozinezhad S</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.; Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Furlong+BA%22">Furlong BA</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+LR%22">O'Sullivan LR</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ng+CF%22">Ng CF</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Choe+Y%22">Choe Y</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Marquez+S%22">Marquez S</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Myers+KC%22">Myers KC</searchLink>; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Weinberg+OK%22">Weinberg OK</searchLink>; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hasserjian+RP%22">Hasserjian RP</searchLink>; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Novak+R%22">Novak R</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Levy+O%22">Levy O</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Prantil-Baun+R%22">Prantil-Baun R</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Novina+CD%22">Novina CD</searchLink>; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shimamura+A%22">Shimamura A</searchLink>; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ewart+L%22">Ewart L</searchLink>; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ingber+DE%22">Ingber DE</searchLink>; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. don.ingber@wyss.harvard.edu.; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA. don.ingber@wyss.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101696896%22">Nature biomedical engineering</searchLink> [Nat Biomed Eng] 2020 Apr; Vol. 4 (4), pp. 477. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696896 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2157-846X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222157846X%22">2157846X </searchLink><i>NLM ISO Abbreviation: </i>Nat Biomed Eng <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32051581 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41551-020-0529-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 477 Titles: – TitleFull: Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chou DB – PersonEntity: Name: NameFull: Frismantas V – PersonEntity: Name: NameFull: Milton Y – PersonEntity: Name: NameFull: David R – PersonEntity: Name: NameFull: Pop-Damkov P – PersonEntity: Name: NameFull: Ferguson D – PersonEntity: Name: NameFull: MacDonald A – PersonEntity: Name: NameFull: Vargel Bölükbaşı Ö – PersonEntity: Name: NameFull: Joyce CE – PersonEntity: Name: NameFull: Moreira Teixeira LS – PersonEntity: Name: NameFull: Rech A – PersonEntity: Name: NameFull: Jiang A – PersonEntity: Name: NameFull: Calamari E – PersonEntity: Name: NameFull: Jalili-Firoozinezhad S – PersonEntity: Name: NameFull: Furlong BA – PersonEntity: Name: NameFull: O'Sullivan LR – PersonEntity: Name: NameFull: Ng CF – PersonEntity: Name: NameFull: Choe Y – PersonEntity: Name: NameFull: Marquez S – PersonEntity: Name: NameFull: Myers KC – PersonEntity: Name: NameFull: Weinberg OK – PersonEntity: Name: NameFull: Hasserjian RP – PersonEntity: Name: NameFull: Novak R – PersonEntity: Name: NameFull: Levy O – PersonEntity: Name: NameFull: Prantil-Baun R – PersonEntity: Name: NameFull: Novina CD – PersonEntity: Name: NameFull: Shimamura A – PersonEntity: Name: NameFull: Ewart L – PersonEntity: Name: NameFull: Ingber DE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2020 Apr Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2157-846X Numbering: – Type: volume Value: 4 – Type: issue Value: 4 Titles: – TitleFull: Nature biomedical engineering Type: main |
| ResultId | 1 |